Search our team at AdventHealth Research Institute
-
Validation of the Pediatric Critical-care Pain Observation Tool (P-COPT) in PICU and Pediatric CVICU
This study is not currently enrolling.Research Area: Pediatric Research and Clinical TrialsThe specific aim of the proposed study is to further validate the P-CPOT in PICU and Pediatric CVICU ventilated patients who are 3 to 18 years.
-
NCT04321031
Prospective Observational Study to Assess Outcomes in Pediatric Liver Transplant Recipients
This study is not currently enrolling.Associated Conditions: TransplantResearch Area: Pediatric Research and Clinical TrialsResearch Location: Orlando, FloridaThe purpose of the study is to collect scientific data on pediatric liver transplantation to learn more about how children do after liver transplant. Collecting this data is expected to help...
-
Robotic-assisted Laparoscopic Varicocelectomy in the Pediatric population
This study is not currently enrolling.Associated Conditions: SurgeryResearch Area: Pediatric Research and Clinical TrialsResearch Location: Orlando, FloridaThe aim of this study is to describe outcomes and complications in robotic varicocelectomy in the pediatric population.
-
Outcomes and Complications of Pediatric Robotic Ureteral Reimplantation
This study is not currently enrolling.Associated Conditions: SurgeryResearch Area: Pediatric Research and Clinical TrialsResearch Location: Orlando, FloridaThe aim of this to describe outcomes and complications in robotic ureteral reimplantation in the pediatric population.
-
NCT03698994
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (ulixertinib) in Patients with Tumors Harboring Activating MAPK Pathway Mutations
This study is not currently enrolling.Associated Conditions: Cancer, Multiple Tumor TypesResearch Area: Pediatric Research and Clinical TrialsYou are being asked to take part in this research study because your tumor results from the NCI-COG Pediatric MATCH screening protocol make you a candidate to receive the study drug called BVD-523FB...
-
NCT03526250
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients with Tumors Harboring Activating Alterations in Cell Cycle Genes
This study is not currently enrolling.Associated Conditions: Cancer, Multiple Tumor TypesResearch Area: Pediatric Research and Clinical TrialsThe main goal of this study is to test any good and bad effects of the palbociclib on your tumor. A second goal of the study is to evaluate side effects that might be caused by palbociclib.
-
NCT03233204
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Olaparib in Patients with Tumors Harboring Defects in DNA Damage Repair Genes
This study is not currently enrolling.Associated Conditions: Cancer, All Tumor TypesResearch Area: Pediatric Research and Clinical TrialsThe main goal is to test any good and bad effects of the study drug olaparib on your tumor. A second goal of the study is to evaluate side effects that might be caused by olaparib and to learn more...
-
NCT03220035
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Vemurafenib in Patients with Tumors Harboring BRAF V600 Mutations
This study is not currently enrolling.Associated Conditions: Cancer, All Tumor TypesResearch Area: Clinical Cancer ResearchResearch Location: Orlando, FloridaYou are being asked to participate in this study because you have relapsed or refractory tumor without a proven treatment strategy for cure. The main goal is to test any good and bad effects of the...
-
NCT03213691
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Selumetinib (AZD6244 Hydrogen Sulfate)in Patients with Tumors Harboring Activating MAPK Pathway Mutations
This study is not currently enrolling.Associated Conditions: Multiple Tumor TypesResearch Area: Pediatric Research and Clinical TrialsResearch Location: Orlando, FloridaThe main goal is to test any good and bad effects of the study drug selumetinib (AZD6244 hydrogen sulfate) on your tumor. A second goal of the study is to evaluate side effects that might be caused by...
-
NCT03213678
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of LY3023414 in Patients with Solid Tumors
This study is not currently enrolling.Associated Conditions: Cancer, Multiple Tumor TypesResearch Area: Pediatric Research and Clinical TrialsResearch Location: Orlando, FloridaThis is a Phase 2 study of a drug called LY3023414. In a Phase 2 study, the goal is to find out what effects, good and/or bad, a drug has on your tumor or type of cancer.
-
NCT02815891
TARGET-NASH: A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver or Nonalcoholic Steatohepatitis
This study is not currently enrolling.Associated Conditions: Liver-NAFL, NASHResearch Area: Translational ResearchTARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH or NAFL in clinical practice. TARGET-NASH will create a carefully maintained, actively monitored research...
-
NCT03574597
SELECT: Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
This study is not currently enrolling.Associated Conditions: Obesity-Drug StudyResearch Area: Translational ResearchSemaglutide is a medicine doctors can prescribe in some countries for the treatment of type 2 diabetes. A completed study showed that semaglutide reduced the risk of cardiovascular events (e.g. heart...